Global Population Suffering from Insomnia
240 Million
Source: Journal of Family Medicine and Primary Care
Conventional treatments for insomnia carry inherent risks
Medications for insomnia come with risks such as daytime drowsiness, digestive issues, muscle wasting, dizziness, and memory loss, as well as the potential for addiction. Drug treatments are not capable of fundamentally curing chronic insomnia.
Although Cognitive Behavioral Therapy (CBT) is recommended as a first-line treatment for insomnia and shows clinical efficacy, the treatment faces challenges such as long treatment duration, high dropout rates, and side effects from sleep restriction therapy.
Our Solution
Overcoming the fundamental limitations of traditional treatment methods
Sleep Thera facilitates sleep initiation by addressing hyperarousal, a primary trigger of insomnia. It shows effects with 10-30 minutes of use before sleep, without posing any side effect risks.
The efficacy has been clinically proven in patients with difficulty falling asleep and in those suffering from acute insomnia caused by hospitalization.
I was using Sleep Thera, and at some point,
I felt like I was being pulled into it.
Sleep Thera UT Participant
We are developing next-generation DTx through the establishment of various R&D partnerships
R&D Partnership with professors from the department of neurology at Seoul National University Hospital, multifaceted collaboration with the department of music therapy at Ewha Womans University, and more..
